Zurich Insurance Group LTD Biogen Inc. Transaction History

Zurich Insurance Group LTD

  • $11.4 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $18.8 Million - $23.4 Million
98,642 New
98,642 $22.9 Million
Q4 2019

Feb 14, 2020
SELL
$220.06 - $304.07 $5.25 Million - $7.26 Million
-23,869 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$217.44 - $243.88 $2.27 Million - $2.54 Million
-10,422 Reduced 30.39%
23,869 $5.56 Million
Q2 2019

Aug 14, 2019
BUY
$219.29 - $241.72 $296,699 - $327,047
1,353 Added 4.11%
34,291 $8.02 Million
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $2.33 Million - $3.64 Million
10,748 Added 48.44%
32,938 $7.79 Million
Q4 2018

Feb 14, 2019
SELL
$278.5 - $352.75 $6.35 Million - $8.04 Million
-22,791 Reduced 50.67%
22,190 $6.68 Million
Q3 2018

Nov 14, 2018
BUY
$293.51 - $383.83 $916,925 - $1.2 Million
3,124 Added 7.46%
44,981 $15.9 Million
Q2 2018

Aug 14, 2018
BUY
$257.52 - $306.91 $2.01 Million - $2.39 Million
7,803 Added 22.91%
41,857 $12.1 Million
Q1 2018

May 15, 2018
BUY
$260.13 - $367.91 $380,830 - $538,620
1,464 Added 4.49%
34,054 $9.33 Million
Q4 2017

Feb 14, 2018
BUY
$307.64 - $344.58 $1.21 Million - $1.35 Million
3,926 Added 13.7%
32,590 $10.4 Million
Q3 2017

Nov 14, 2017
BUY
$281.15 - $329.69 $8.06 Million - $9.45 Million
28,664
28,664 $8.98 Million

Others Institutions Holding BIIB

# of Institutions
1,035
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Zurich Insurance Group LTD Portfolio

Follow Zurich Insurance Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zurich Insurance Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email